Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
5Customers
3Debt Items
0Related Chains
Source-Backed Evidence Depth
Envoy Medical, Inc. (COCH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
11Total relationships
2Distinct source URLs
8High confidence
0.818Average confidence
2026-07-01Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Envoy Medical, Inc. Suppliers
Ticker
Name
Confidence
Evidence
GAT-FUNDING-LLC
GAT-FUNDING-LLC
92%
In February 2024, the Company issued a promissory note (the “February 2024 Term Loan”) with a minimum principal amount of $ 5,000 and up to $ 10,000 to GAT Funding, LLC (“GAT”), an entity controlled …
GLEN-A-TAYLOR
GLEN-A-TAYLOR
92%
In February 2024, the Company issued a promissory note (the “February 2024 Term Loan”) with a minimum principal amount of $ 5,000 and up to $ 10,000 to GAT Funding, LLC (“GAT”), an entity controlled …
Envoy Medical, Inc. Customers
Ticker
Name
Confidence
Evidence
ANZU-SPAC-GP-I-LLC
ANZU-SPAC-GP-I-LLC
85%
On November 14, 2023, the Company, Whitney Haring-Smith (the former chief executive officer and a former director of the Company), Daniel Hirsch (the former chief financial officer of the Company), a…
ATLAS-MERCHANT-CAPITAL-SPAC-FUND-I-LP
ATLAS-MERCHANT-CAPITAL-SPAC-FUND-I-LP
85%
On November 14, 2023, the Company, Whitney Haring-Smith (the former chief executive officer and a former director of the Company), Daniel Hirsch (the former chief financial officer of the Company), a…
ANZU-ENVOY-MEDICAL-CORPORATION
ANZU-ENVOY-MEDICAL-CORPORATION
62%
. The principal amount drawn bore interest at a rate of 8.0 % per annum and was to be paid quarterly in arrears after the second anniversary of the March 2025 Term Loan. Interest accrued and was not …
ANZU-SPECIAL-ACQUISITION-CORP
ANZU-SPECIAL-ACQUISITION-CORP
62%
in other territories, and good laboratory practices, which are regulations and guidelines enforced by the FDA, the Competent Authorities of the Member States of the EEA, and comparable foreign regula…
EMERGING-GROWTH-COMPANY
EMERGING-GROWTH-COMPANY
62%
e supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Management uses valuation techniques in measuring the fair value of financial inst…
Envoy Medical, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
COCH-DEBT-8763
Warrants outstanding: 500000
90%
xbrl warrant detail from xbrl 2025-12-31.
COCH-DEBT-8764
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2023-12-31.
COCH-DEBT
Debt stack $889,000
90%
Market cache reports total debt of $889,000.
Envoy Medical, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Envoy Medical, Inc..
Envoy Medical, Inc. Ownership
Holder
Name
Confidence
Evidence
COCH-OWNER-ARISTEIA-CAPITAL-L-L-C
ARISTEIA CAPITAL, L.L.C.
90%
13F overlay lists ARISTEIA CAPITAL, L.L.C. as top holder; 36 tracked holders.
Envoy Medical, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
